Immune Design partners with 2 nonprofits on cancer immunotherapy

06/13/2013 | Xconomy

Immune Design will work with the Ludwig Institute for Cancer Research and the Cancer Research Institute to test a vaccine and adjuvant in ongoing clinical trials for other cancer immunotherapies. The Column Group, Versant Ventures and Alta Partners have invested $50 million in Immune Design, and the CEO expects to launch a new funding round soon.

View Full Article in:

Xconomy

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA